医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Video of Mannatech’s Pure Aloe “Manapol Powder” Available on Business Wire’s Website

2017年04月07日 AM01:36
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

GUANGZHOU, China

A video is available on Business Wire’s Website featuring Mannatech®, Incorporated’s pure aloe product, Manapol® powder, the foundation of Mannatech’s nutritional supplement technology in China.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170406006024/en/

In this video, Mannatech’s CEO and President, Alfredo “Al” Bala, and Senior Global Wellness Director, Dr. Steve Nugent, talk about Mannatech’s Manapol powder as the purest and best source of aloe vera’s healthful properties. Manapol is a powerful element included in Mannatech’s Glyconutritional technology that is part of nearly all of its supplement products available in China through its cross-border e-commerce website, www.MeiTaiChina.com. † This includes its top selling product in China, Advanced Ambrotose®, which is fortified with Manapol and is clinically proven to boost the immune system, support digestive function and support cognitive function, including memory, mood and concentration.

Watch the video to learn more.

† Mannatech’s cross-border e-commerce model in China is a different opportunity from Mannatech’s MLM business in other markets. Customers who invite other customers to the Mannatech China cross-border e-commerce site gain rewards for future product purchases or cash redemption. The e-commerce business model is not multi-level marketing or direct selling.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170406006024/en/

CONTACT

Mannatech, Incorporated
Kalyn Dabbs, 972-471-7245
pr@mannatech.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 20/20’s Lung Cancer Detection Technology Launches in China
  • PAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
  • PREVENA™ Incision Management System Shown to Reduce Incisional Pain and Associated Narcotic Use Among Obese Study Patients Undergoing Cesarean Delivery
  • Samsung Bioepis and Takeda Sign Strategic Collaboration Agreement to Co-Develop Multiple Novel Biologic Therapies
  • Ligand to Receive $2 Million from WuXi Biologics for Licensing Clinical-Stage anti-PD-1 Antibody Discovered Using the OmniAb® Technology